Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Shim

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|December 2, 2000
Surgical pearl: repair of helical rim defects with the bipedicle advancement flapE K Shim, H T Greenway
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 10, 2001
Microdermabrasion: a clinical and histopathologic studyE K Shim, D Barnette, K Hughes, et al.
Obstetrics and Gynecology|June 1, 1996
A comparison of once-daily and 8-hour gentamicin dosing in the treatment of postpartum endometritisG Del Priore, M Jackson-Stone, E K Shim, et al.
British Journal of Cancer|August 22, 2013
S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysisS Y Kim, Y S Hong, E K Shim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|December 2, 2000
Surgical pearl: repair of helical rim defects with the bipedicle advancement flapE K Shim, H T Greenway
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 10, 2001
Microdermabrasion: a clinical and histopathologic studyE K Shim, D Barnette, K Hughes, et al.
Obstetrics and Gynecology|June 1, 1996
A comparison of once-daily and 8-hour gentamicin dosing in the treatment of postpartum endometritisG Del Priore, M Jackson-Stone, E K Shim, et al.
British Journal of Cancer|August 22, 2013
S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysisS Y Kim, Y S Hong, E K Shim, et al.
Pageof 1